Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II

Steroids

Volumn 88, Issue , 2014, Pages 117-126

  Traish, Abdulmaged M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body composition; Cardiovascular risk; Dyslipidemia; Insulin sensitivity; Mortality; Testosterone therapy

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIVER ENZYME; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ANDROGEN DEFICIENCY; ANDROGEN THERAPY; BODY MASS; BODY WEIGHT; BONE DENSITY; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; ERECTILE DYSFUNCTION; FAT MASS; FATIGUE; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MUSCLE MASS; OBESITY; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; DEFICIENCY; MALE; TREATMENT OUTCOME;

COMORBIDITY; HUMANS; MALE; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84907598449     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2014.05.004     Document Type: Review

References (164)

1. A. Traish Adverse health effects of testosterone deficiency (TD) in men Steroids 88 2014 106 116
2. J.C. Aub The use of testosterone N Engl J Med 222 1940 877 881
3. J.C. Aub, and S.S. Kety Recent advances in testosterone therapy N Engl J Med 228 1943 338 343
4. F. Saad, A. Haider, G. Doros, and A. Traish Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss Obesity (Silver Spring) 21 2013 1975 1981
5. A. Haider, F. Saad, G. Doros, and L. Gooren Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study Obes Res Clin Pract 2013
6. A. Haider, A. Yassin, G. Doros, and F. Saad Effects of long-term testosterone therapy on patients with "Diabesity": results of observational studies of pooled analyses in obese hypogonadal men with type 2 diabetes Int Endocrinol 2014 2014 683515201
7. A. Yassin, and G. Doros Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss Clin Obes 3 2013 73 83
8. A.M. Traish, A. Haider, G. Doros, and F. Saad Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study Int J Clin Pract 68 2014 314 319
9. C. Chrysohoou, D. Panagiotakos, C. Pitsavos, G. Siasos, E. Oikonomou, and J. Varlas et al. Low total testosterone levels are associated with the metabolic syndrome in elderly men: the role of body weight, lipids, insulin resistance, and inflammation; the Ikaria study Rev Diabetes Stud 10 1 2013 27 38
10. S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, L.J. Gooren, E.J. Giltay, and F. Saad Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study Clin Endocrinol (Oxf) 73 2010 602 612
11. D. Kapoor, S. Clarke, R. Stanworth, K.S. Channer, and T.H. Jones The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes Eur J Endocrinol 156 5 2007 595 602
12. V. Bhatia, A. Chaudhuri, R. Tomar, S. Dhindsa, H. Ghanim, and P. Dandona Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes Diabetes Care 29 10 2006 2289 2294
13. S.K. Musani, R.S. Vasan, and A. Bidulescu et al. Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson heart study Diabetes Care 36 10 2013 3084 3092
14. O. Schnell, I. Amann-Zalan, and Z. Jelsovsky et al. Changes in A1C levels are significantly associated with changes in levels of the cardiovascular risk biomarker hs-CRP: results from the SteP study Diabetes Care 36 7 2013 2084 2089
15. D. Francomano, A. Ilacqua, R. Bruzziches, A. Lenzi, and A. Aversa Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome Urology 83 1 2014 167 174
16. C. Wang, G. Jackson, T.H. Jones, A.M. Matsumoto, A. Nehra, and M.A. Perelman et al. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes Diabetes Care 34 2011 1669 1675
17. C.M. Hoyos, B.J. Yee, C.L. Phillips, E.A. Machan, R.R. Grunstein, and P.Y. Liu Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial Eur J Endocrinol 167 2012 531 541
18. U. Pagotto, A. Gambineri, C. Pelusi, S. Genghini, M. Cacciari, and B. Otto et al. Testosterone replacement therapy restores normal ghrelin in hypogonadal men J Clin Endocrinol Metab 88 2003 4139 4143
19. D. Kapoor, E. Goodwin, K.S. Channer, and T.H. Jones Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes Eur J Endocrinol 154 2006 899 906
20. P. Mårin, M. Krotkiewski, and P. Björntorp Androgen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues Eur J Med 1 1992 329 336
21. P. Mårin, S. Holmäng, C. Gustafsson, L. Jönsson, H. Kvist, and A. Elander Androgen treatment of abdominally obese men Obes Res 1 1993 245 251
22. A.E. Heufelder, F. Saad, M.C. Bunck, and L. Gooren Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone J Androl 30 2009 726 733
23. M.A. Boyanov, Z. Boneva, and V.G. Christov Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency Aging Male 6 2003 1 7
24. M.I. Naharci, M. Pinar, E. Bolu, and A. Olgun Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism Endocr Pract 13 2007 629 635
25. N. Pitteloud, M. Hardin, A.A. Dwyer, E. Valassi, M. Yialamas, and D. Elahi et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men J Clin Endocrinol Metab 90 2005 2636 2641
26. N. Pitteloud, V.K. Mootha, A.A. Dwyer, M. Hardin, H. Lee, and K.F. Eriksson et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men Diabetes Care 28 2005 1636 1642
27. R.K. Bhattacharya, M. Khera, G. Blick, H. Kushner, D. Nguyen, and M.M. Miner Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS) BMC Endocr Disord 11 2011 18 29
28. M. Zitzmann, A. Mattern, J. Hanisch, L. Gooren, H. Jones, and M. Maggi IPASS: a Study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1438 men J Sex Med 10 2013 579 588
29. G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, and P. Wilkinson et al. Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study J Sex Med 11 3 2014 840 856
30. M. Grossmann Testosterone and glucose metabolism in men: current concepts and controversies J Endocrinol 220 3 2014 R37 R55
31. J. Svartberg, I. Agledahl, Y. Figenschau, T. Sildnes, K. Waterloo, and R. Jorde Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip Int J Impot Res 20 2008 378 387
32. C.A. Allan, B.J. Strauss, H.G. Burger, E.A. Forbes, and R.I. McLachlan Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in non-obese aging men J Clin Endocrinol Metab 93 2008 139 146
33. H.M. Behre, T.L. Tammela, S. Arver, J.R. Tolrá, V. Bonifacio, and M. Lamche A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up Aging Male 15 2012 198 207
34. A. Aversa, R. Bruzziches, D. Francomano, E.A. Greco, R. Fornari, and L. Di Luigi et al. Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study Aging Male 15 2012 96 102
35. E.J. Hamilton, E. Gianatti, B.J. Strauss, J. Wentworth, D. Lim-Joon, and D. Bolton et al. Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy Clin Endocrinol 74 2011 377 383
36. C. De Maddalena, S. Vodo, A. Petroni, and A.M. Aloisi Impact of testosterone on body fat composition J Cell Physiol 227 2012 3744 3748
37. S. Bhasin, T.G. Travison, T.W. Storer, K. Lakshman, M. Kaushik, and N.A. Mazer et al. Effect of testosterone supplementation with and without a dual 5α-reductase inhibitor on fat-free mass in men with suppressed testosterone production: a randomized controlled trial JAMA 307 2012 931 939
38. J.S. Finkelstein, H. Lee, S.A. Burnett-Bowie, J.C. Pallais, E.W. Yu, and L.F. Borges et al. Gonadal steroids and body composition, strength, and sexual function in men N Engl J Med 369 2013 1011 1022
39. U. Srinivas-Shankar, S.A. Roberts, M.J. Connolly, M.D. O'Connell, J.E. Adams, and J.A. Oldham Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study J Clin Endocrinol Metab 95 2010 639 650
40. A.M. Isidori, E. Giannetta, E.A. Greco, D. Gianfrilli, V. Bonifacio, and A. Isidori et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis Clin Endocrinol (Oxf) 63 3 2005 Sep 280 293
41. A. Traish, A. Rami, and K.E. Kypreos Androgen deficiency and atherosclerosis: the lipid link Vasc Pharmacol 51 2009 303 313
42. M.H. Emmelot-Vonk, H.J.J. Verhaar, H.R. Nakhai Pour, A. Aleman, T.M.T.W. Lock, and J.L.H. Ruud Bosch et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older age. A randomized controlled trial J Am Med Assoc 299 2008 39 52
43. E.F. Saad, L. Gooren, A. Haider, and A. Yassin An exploratory study of the effects of 12-month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome Arch Androl 53 2007 353 357
44. F. Saad, L.J. Gooren, A. Haider, and A. Yassin A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate J Androl 29 2008 102 105
45. M. Zitzmann, and E. Nieschlag Androgen receptor gene CAG repeat length and body mass index modulate the safety of long term intramuscular testosterone undecanoate therapy in hypogonadal men J Clin Endocrinol Metab 92 2007 3844 3853
46. S.T. Page, J.K. Amory, F.D. Bowman, B.D. Anawalt, A.M. Matsumoto, and W.J. Bremner et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T J Clin Endocrinol Metab 90 2005 1502 1510
47. C.J. Malkin, P.J. Pugh, R.D. Jones, D. Kapoor, K.S. Channer, and T.H. Jones The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profile in hypogonadal men J Clin Endocrinol Metab 89 2004 3313 3318
48. A.S. Dobs, P.S. Bachorik, S. Arver, A.W. Meikle, S.W. Sanders, and K.E. Caramelli Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system J Clin Endocrinol Metab 86 2001 1026 1033
49. K.C. Chen, C.C. Peng, H.M. Hsieh, C.H. Peng, C.L. Hseih, and C.N. Hunag et al. Antiandrogenic therapy can cause coronary arterial disease Int J Urol 12 2005 886 891
50. T. Nishiyama, F. Ishizaki, T. Anraku, H. Shimura, and K. Takahashi The influence of androgen deprivation therapy on metabolism in patients with prostate cancer J Clin Endocrinol Metab 90 2005 657 660
51. M.R. Smith, H. Lee, and D.M. Nathan Insulin sensitivity during combined androgen blockade for prostate cancer J Clin Endocrinol Metab 91 2006 1305 1308
52. M. Zitzmann, and E. Nieschlag Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men J Clin Endocrinol Metab 92 2007 3844 5360
53. S.T. Page, K.L. Herbst, and J.K. Amory et al. Testosterone administration suppresses adiponectin levels in men J Androl 26 2005 85 92
54. A.K. Monroe, and A.S. Dobs The effect of androgens on lipids Curr Opin Endocrinol Diabetes Obes 20 2013 132 139
55. S. Permpongkosol, N. Tantirangsee, and K. Ratana-olarn Treatment of 161 men with symptomatic late onset hypogonadism with long-acting parenteral testosterone undecanoate: effects on body composition, lipids, and psychosexual complaints J Sex Med 7 2010 3765 3774
56. T.H. Jones, S. Arver, H.M. Behre, J. Buvat, E. Meuleman, and I. Moncada et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 Study) Diabetes Care 34 2011 828 837
57. T.H. Jones Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome J Diabetes 2 2010 146 156
58. P. Mårin Testosterone and regional fat distribution Obes Res 3 Suppl. 4 1995 S609 S612
59. P. Mårin, L. Lonn, B. Andersson, B. Oden, L. Olbe, and B.A. Bengtsson et al. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone J Clin Endocrinol Metab 81 1996 1018 1022
60. R.S. Swerdloff, and C. Wang Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel Aging Male 6 2003 207 211
61. S. Zgliczynski, M. Ossowski, J. Slowinska-Srzednicka, A. Brzezinska, W. Zgliczynski, and P. Soszynski et al. Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men Atherosclerosis 121 1996 35 43
62. J.F. Reckelhoff Gender differences in the regulation of blood pressure Hypertension 37 5 2001 1199 1208
63. R.K. Dubey, S. Oparil, B. Imthum, and E.K. Jackson Sex hormones and hypertension Cardiovasc Res 53 3 2002 688 708
64. C.A. Koch, and M. Zitzmann Testosterone deficiency or male hypogonadism C.A. Koch, G.P. Chrousos, Contemporary endocrinology: endocrine hypertension 2013 Springer New York
65. J. Svartberg, D. von Mühlen, H. Schirmer, E. Barrett-Connor, J. Sundfjord, and R. Jorde Association of endogenous testosterone with blood pressure and left ventricular mass in men Tromsø Stud Eur J Endocrinol 150 2004 65 71
66. J.Y. Li, J.C. Zhu, and J.T. Dou et al. Effects of androgen supplementation therapy on partial androgen deficiency in the aging male: a preliminary study Aging Male 5 2002 47 51
67. J.C. Smith, S. Bennett, L.M. Evans, H.G. Kynaston, M. Parmar, and M.D. Mason et al. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer J Clin Endocrinol Metab 86 2001 4261 4267
68. F. Dockery, C.J. Bulpitt, S. Agarwal, M. Donaldson, and C. Rajkumar Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia Clin Sci 104 2003 195 201
69. C. Ohlsson, E. Barrett-Connor, S. Bhasin, E. Orwoll, F. Labrie, and M. Karlsson et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic fractures in men) study in Sweden J Am Coll Cardiol 58 2011 1674 1682
70. M.I. Ullah, T. Washington, M. Kazi, S. Tamanna, and C.A. Koch Testosterone deficiency as a risk factor for cardiovascular disease Horm Metab Res 43 3 2011 153 164 10.1055/s-0030-1270521 [Epub 2011 Jan 31]
71. A. Aversa, R. Bruzziches, D. Francomano, G. Rosano, A.M. Isidori, and A. Lenzi et al. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study J Sex Med 7 2010 3495 3503
72. A. Aversa, R. Bruzziches, D. Francomano, G. Spera, and A. Lenzi Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome J Endocrinol Invest 33 2010 776 783
73. I. Lemieux, B. Lamarche, C. Couillard, A. Pascot, B. Cantin, and J. Bergeron et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec cardiovascular study Arch Intern Med 161 2001 2685 2692
74. D.M. Kelly, and T.H. Jones Testosterone: a vascular hormone in health and disease J Endocrinol 217 3 2013 R47 R71
75. D.M. Kelly, and T.H. Jones Testosterone: a metabolic hormone in health and disease J Endocrinol 217 3 2013 R25 R45
76. P.M. Rao, D.M. Kelly, and T.H. Jones Testosterone and insulin resistance in the metabolic syndrome and T2DM in men Nat Rev Endocrinol 9 8 2013 479 493
77. M.M. Shores, N.L. Smith, C.W. Forsberg, B.D. Anawalt, and A.M. Matsumoto Testosterone treatment and mortality in men with low testosterone levels J Clin Endocrinol Metab 97 2012 2050 2058
78. V. Muraleedharan, H. Marsh, D. Kapoor, K.S. Channer, and T.H. Jones Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes Eur J Endocrinol 169 2013 725 733
79. S.P. Zhao, and X.P. Li The association of low plasma testosterone level with coronary artery disease in Chinese men Int J Cardiol 63 1998 161 164
80. S. Dobrzycki, W. Serwatka, S. Nadlewski, J. Korecki, R. Jackowski, J. Paruk, J.R. Ladny, and T. Hirnle An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males J Med Invest 50 2003 162 169
81. M. Akishita, M. Hashimoto, Y. Ohike, S. Ogawa, K. Iijima, M. Eto, and Y. Ouchi Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors Atherosclerosis 210 2010 232 236
82. X. Hu, L. Rui, T. Zhu, H. Xia, X. Yang, X. Wang, H. Liu, Z. Lu, and H. Jiang Lowtestosterone level in middle-aged male patients with coronary artery disease Eur J Intern Med 22 2011 e133 136
83. L. Li, C.Y. Guo, E.Z. Jia, T.B. Zhu, L.S. Wang, K.J. Cao, W.Z. Ma, and Z.J. Yang Testosterone is negatively associated with the severity of coronary atherosclerosis in men Asian J Androl 14 2012 875 878
84. G.B. Phillips, B.H. Pinkernell, and T.Y. Jing The association of hypotestosteronemia with coronary artery disease in men Arterioscler Thromb 14 1994 701 706
85. G. Hackett, M. Kirby, and A.J. Sinclair Testosterone deficiency, cardiac health, and older men Int J Endocrinol 2014 2014 143763
86. M. Muller, A.W. van den Beld, M.L. Bots, D.E. Grobbee, S.W. Lamberts, and Y.T. van der Schouw Endogenous sex hormones and progression of carotid atherosclerosis in elderly men Circulation 109 2004 2074 2079
87. K.K. Khurana, S.D. Navaneethan, S. Arrigain, J.D. Schold, J.V. Nally Jr, and D.A. Shoskes Serum testosterone levels and mortality in men with CKD stages 3-4 Am J Kidney Dis 2014
88. M. Toma, F.A. McAlister, E.E. Coglianese, V. Vidi, S. Vasaiwala, and J.A. Bakal et al. Testosterone supplementation in heart failure: a meta-analysis Circ Heart Fail 5 2012 315 321
89. G. Corona, G. Rastrelli, M. Monami, A. Guay, J. Buvat, and A. Sforza et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study Eur J Endocrinol 165 2011 687 701
90. A.B. Araujo, J.M. Dixon, E.A. Suarez, M.H. Murad, L.T. Guey, and G.A. Wittert Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis J Clin Endocrinol Metab 96 2011 3007 3019
91. G. Corona, G. Rastrelli, L. Vignozzi, E. Mannucci, and M. Maggi Testosterone, cardiovascular disease and the metabolic syndrome Best Pract Res Clin Endocrinol Metab 25 2011 337 353
92. J.B. Ruige, A.M. Mahmoud, D. De Bacquer, and J.M. Kaufman Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis Heart 97 2011 870 875
93. R.M. Haddad, C.C. Kennedy, S.M. Caples, M.J. Tracz, E.R. Boloña, and K. Sideras et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials Mayo Clin Proc 82 2007 29 39
94. M.M. Fernández-Balsells, M.H. Murad, M. Lane, J.F. Lampropulos, F. Albuquerque, and R.J. Mullan et al. Clinical review 1: adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis J Clin Endocrinol Metab 95 2010 2560 2575
95. P.M. Oskui, W.J. French, M.J. Herring, G.S. Mayeda, S. Burstein, and R.A. Kloner Testosterone and the cardiovascular system: a comprehensive review of the clinical literature J Am Heart Assoc 2 2013 e000272
96. T.H. Jones Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab 21 2010 496 503
97. C.C. Carson, and G. Rosano Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data J Sex Med 9 2012 54 67
98. M. Stout, G.A. Tew, H. Doll, I. Zwierska, N. Woodroofe, and K.S. Channer et al. Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study Am Heart J 164 2012 893 901
99. J. Makinen, M. Jarvisalo, P. Pollanen, A. Perheentupa, K. Irjala, and M. Koskenvuo et al. Increased carotid atherosclerosis in andropausal middle-aged men J Am Coll Cardiol 45 2005 1603 1608
100. A.W. van den Beld, M.L. Bots, J.A.M.L.L. Janssen, H.A.P. Pols, S.W.J. Lamberts, and D.E. Grobbee Endogenous hormones and carotid atherosclerosis in elderly men Am J Epidemiol 157 2003 25 31
101. G. De Pergola, N. Pannacciulli, M. Ciccone, M. Tartagni, P. Rizzon, and R. Giorgino Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men Int J Obes Relat Metab Disord 27 2003 803 807
102. L. Fu, Q.P. Gao, and J.X. Shen Relationship between testosterone and indexes indicating endothelial function in male coronary heart disease patients Asian J Androl 10 2008 214 218
103. J. Svartberg, D. Von Muhlen, E. Mathiesen, O. Joakimsen, K.H. Bonaa, and E. Stensland-Bugge Low testosterone levels are associated with carotid atherosclerosis in men J Intern Med 259 2006 576 582
104. M. Fukui, Y. Kitagawa, N. Nakamura, M. Kadono, S. Mogami, and C. Hirata et al. Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes Diabetes Care 26 2003 1869 1873
105. J.J. Naghi, K.J. Philip, D. DiLibero, R. Willix, and E.R. Schwarz Testosterone therapy: treatment of metabolic disturbances in heart failure J Cardiovasc Pharmacol Ther 16 2011 14 23
106. G. Caminiti, M. Volterrani, F. Iellamo, G. Marazzi, R. Massaro, and M. Miceli et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study J Am Coll Cardiol 54 2009 919 927
107. A. Mathur, C. Malkin, B. Saeed, R. Muthusamy, T.H. Jones, and K. Channer Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men Eur J Endocrinol 161 2009 443 449
108. C.J. Malkin, P.J. Pugh, J.N. West, E.J. van Beek, T.H. Jones, and K.S. Channer Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial Eur Heart J 27 2006 57 64
109. P.J. Pugh, R.D. Jones, J.N. West, T.H. Jones, and K.S. Channer Testosterone treatment for men with chronic heart failure Heart 90 2004 446 447
110. P. Aukrust, T. Ueland, L. Gullestad, and A. Yndestad Testosterone: a novel therapeutic approach in chronic heart failure? J Am Coll Cardiol 54 2009 928 929
111. R. Vigen, C.I. O'Donnell, A.E. Baron, G.K. Grunwald, T.M. Maddox, and S.M. Bradley et al. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels JAMA 310 2013 1829 1836
112. S. Basaria, A.D. Coviello, T.G. Travison, T.W. Storer, W.R. Farwell, and A.M. Jette et al. Adverse events associated with testosterone administration N Engl J Med 363 2010 109 122
113. A.M. Traish, A.T. Guay, and A. Morgentaler Death by testosterone? We think not! J Sex Med 11 3 2014 624 629 10.1111/jsm.12464
114. A. Morgentaler, A. Traish, and R. Kacker Deaths and cardiovascular events in men receiving testosterone JAMA 311 9 2014 961 962 10.1001/jama.2014.392
115. D.M. Riche, W.L. Baker, and C.A. Koch Deaths and cardiovascular events in men receiving testosterone JAMA 311 9 2014 963 964 10.1001/jama.2014.386
116. T.H. Jones, and K.S. Channer Deaths and cardiovascular events in men receiving testosterone JAMA 311 9 2014 962 963 10.1001/jama.2014.398
117. J. Katz, and R. Nadelberg Deaths and cardiovascular events in men receiving testosterone JAMA 311 9 2014 963 10.1001/jama.2014.395
118. A. Morgentaler, and R. Kacker Andrology: testosterone and cardiovascular risk-deciphering the statistics Nat Rev Urol 11 3 2014 131 132 10.1038/nrurol.2014.24 [Epub 2014 Feb 18]
119. S. Dhindsa, M. Batra, and P. Dandona Deaths and cardiovascular events in men receiving testosterone JAMA 311 9 2014 964 10.1001/jama.2014.389
120. G. Irwin Knowledge is power J Sex Med 11 3 2014 613 615 10.1111/jsm.12466
121. W.D. Finkle, S. Greenland, G.K. Ridgeway, J.L. Adams, M.A. Frasco, and M.B. Cook et al. Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men PLoS One 9 1 2014 e85805
122. S.-F. Tong, C.-J. Ng, B.-C. Lee, V.-K. Lee, E.-M. Khoo, and E.-G. Lee et al. Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial Asian J Androl 14 2012 604 611
123. A.M. Isidori, J. Buvat, G. Corona, I. Goldstein, E.A. Jannini, and A. Lenzi et al. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment - a systematic review Eur Urol 65 2014 99 112
124. J. Kang 2nd, B.K. Ham, M.M. Oh, J.J. Kim, and G. Moon du Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome Korean J Urol 52 2011 416 420
125. B.C. Jacob Testosterone replacement therapy in males with erectile dysfunction J Pharm Pract 24 2011 298 306
126. A. Morales Androgens are fundamental in the maintenance of male sexual health Curr Urol Rep 12 2011 453 460
127. A.M. Traish, I. Goldstein, and N.N. Kim Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction Eur Urol 52 2007 54 70
128. F. Saad, A.S. Grahl, A. Aversa, A.A. Yassin, A. Kadioglu, and I. Moncada et al. Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction BJU Int 99 2007 988 992
129. E.R. Boloña, M.V. Uraga, R.M. Haddad, M.J. Tracz, K. Sideras, and C.C. Kennedy et al. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials Mayo Clin Proc 82 2007 20 28
130. M.D. Mitkov, I.Y. Aleksandrova, and M.M. Orbetzova Effect of transdermal testosterone or alpha-lipoic acid on erectile dysfunction and quality of life in patients with type 2 diabetes mellitus Folia Med (Plovdiv) 55 2013 55 63
131. C.A. Allan, E.A. Forbes, B.J. Strauss, and R.I. McLachlan Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency Int J Impot Res 20 2008 396 401
132. B.B. Yeap Testosterone and sex in older men Med J Aust 195 2011 61 62
133. C. Pexman-Fieth, H.M. Behre, A. Morales, N. Kan-Dobrosky, and M.G. Miller A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel Aging Male 2014
134. G. Hackett, N. Cole, M. Bhartia, D. Kennedy, J. Raju, and P. Wilkinson Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes J Sex Med 10 2013 1612 1627
135. R. Amiaz, H.G. Pope Jr, T. Mahne, J.F. Kelly, B.P. Brennan, and G. Kanayama et al. Testosterone gel replacement improves sexual function in depressed men taking serotonergic antidepressants: a randomized, placebo-controlled clinical trial J Sex Marital Ther 37 2011 243 254
136. Y. Kido, S. Sakazume, Y. Abe, Y. Oto, H. Itabashi, and M. Shiraishi et al. Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome: an observational study Am J Med Genet A 161 2013 2167 2173
137. C.C. Ho, S.F. Tong, W.Y. Low, C.J. Ng, E.M. Khoo, and V.K. Lee et al. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the aging male symptoms scale BJU Int 110 2012 260 265
138. A. Tsujimura The relationship between testosterone deficiency and men's health World J Mens Health 31 2013 126 135
139. S.N. Seidman, and M. Weiser Testosterone and mood in aging men Psychiatr Clin North Am 36 2013 177 182
140. B.B. Yeap Are declining testosterone levels a major risk factor for ill-health in aging men? Int J Impot Res 21 2009 24 36
141. D. Glintborg, T.L. Nielsen, K. Wraae, D. Hougaard, C. Gudex, and K. Brixen et al. The relationship between health-related quality of life, obesity and testosterone levels in older men Age Ageing 2013
142. L. Lašaitė, J. Ceponis, R.T. Preikša, and B. Zilaitienė Impaired emotional state, quality of life and cognitive functions in young hypogonadal men Andrologia 2013
143. J.A. Pearl, D. Berhanu, N. François, P. Masson, S. Zargaroff, and J. Cashy et al. Testosterone supplementation does not worsen lower urinary tract symptoms J Urol 190 2013 1828 1833
144. F. Strollo, G. Strollo, M. Morè, P. Magni, C. Macchi, and M.A. Masini et al. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients Aging Male 16 2013 33 37
145. M. Amore, M. Innamorati, S. Costi, L. Sher, P. Girardi, and M. Pompili Partial androgen deficiency, depression, and testosterone supplementation in aging men Int J Endocrinol 2012 2012 280724
146. G.A. Laughlin, E. Barrett-Connor, and J. Bergstrom Low serum testosterone and mortality in older men J Clin Endocrinol Metab 93 2008 68 75
147. K.T. Khaw, M. Dowsett, E. Folkerd, S. Bingham, N. Wareham, and R. Luben et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study Circulation 116 2007 2694 2701
148. R. Haring, H. Volzke, A. Steveling, A. Krebs, S.B. Felix, and C. Schofl et al. Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79 Eur Heart J 31 2010 1494 1501
149. C.J. Malkin, P.J. Pugh, P.D. Morris, S. Asif, T.H. Jones, and K.S. Channer Low serum testosterone and increased mortality in men with coronary heart disease Heart 96 2010 1821 1825
150. A. Tivesten, L. Vandenput, F. Labrie, M.K. Karlsson, O. Ljunggren, and D. Mellstrom et al. Low serum testosterone and estradiol predict mortality in elderly men J Clin Endocrinol Metab 94 2009 2482 2488
151. A. Menke, E. Guallar, S. Rohrmann, W.G. Nelson, N. Rifai, and N. Kanarek et al. Sex steroid hormone concentrations and risk of death in US men Am J Epidemiol 171 2010 583 592
152. T. Vikan, H. Schirmer, I. Njolstad, and J. Svartberg Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso Study Eur J Endocrinol 161 2009 435 442
153. G. Corona, M. Monami, V. Boddi, M. Cameron-Smith, A.D. Fisher, and G. de Vita et al. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction J Sex Med 7 2010 1557 1564
154. Z. Hyde, P.E. Norman, L. Flicker, G.J. Hankey, O.P. Almeida, and K.A. McCaul et al. Low free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men Study J Clin Endocrinol Metab 97 2012 179 189
155. S.R. Pye, I.T. Huhtaniemi, J.D. Finn, D.M. Lee, T.W. O'Neill, and A.
156. W.P. Conners III, and A. Morgentaler The evaluation and management of testosterone deficiency: the new frontier in urology and men's health Curr Urol Rep 14 2013 557 564
157. R.L. Muller, L. Gerber, D.M. Moreira, G. Andriole, R. Castro-Santamaria, and S.J. Freedland Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the reduction by dutasteride of prostate cancer events trial Eur Urol 62 2012 757 764
158. A. Morgentaler Goodbye androgen hypothesis, hello saturation model Eur Urol 62 2012 765 767
159. L. Xu, G. Freeman, B.J. Cowling, and C.M. Schooling Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials BMC Med 11 2013 108
160. G.M. Rosano, F. Leonardo, P. Pagnotta, F. Pelliccia, and G. Panina et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease Circulation 99 1999 1666 1670
161. K.M. English, R.P. Steeds, T.H. Jones, M.J. Diver, and K.S. Channer Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study Circulation 102 2000 1906 1911
162. C.J. Malkin, P.J. Pugh, P.D. Morris, K.E. Kerry, and R.D. Jones et al. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life Heart 90 2004 871 876
163. A. Cornoldi, G. Caminit, G. Marazzi, C. Vitale, and R. Patrizi et al. Effects of chronic testosterone administration on myocardial ischaemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary disease Int J Cardiol 142 2010 50 55
164. M.M. Shores, A.M. Matsumoto, K.L. Sloan, and D.R. Kivlahan Low serum testosterone and mortality in male veterans Arch Intern Med 166 2006 1660 1665